TO ALL FEMINISTS: PLEASE GATHER THE NECESSARY GENETIC TEST KITS FOR BREAST CANCER PATIENTS:
http://www.cnn.com/2016/11/02/health/women-cancer-deaths-2030/index.html
http://www.breastcancer.org/symptoms/testing/genetic/pos_results
http://www.healthline.com/health/her2-positive-breast-cancer-genes-hereditary
TRIPLE-NEGATIVE BREAST CANCER (ALSO REFERRED TO AS "TNBC") CLINICAL TRIALS ARE NECESSARY FOR "TRIPLE INHIBITOR THERAPY": INHIBITING PARP, RECEPTORS FOR ANDROGEN, AND RUNX1.
http://scienceblog.cancerresearchuk.org/2014/06/30/its-time-to-be-positive-about-triple-negative-breast-cancer/
TNBC/TRIPLE-NEGATIVE BREAST CANCER PATIENTS AND PROGNOSTIC ROLES (SURVIVAL RATE PREDUCTIONS), AS IT RELATES TO THEIR BRCA1 GENETIC MUTATIONS:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3861604/
http://www.breastcancer.org/symptoms/testing/genetic/pos_results
http://www.healthline.com/health/her2-positive-breast-cancer-genes-hereditary
TRIPLE-NEGATIVE BREAST CANCER (ALSO REFERRED TO AS "TNBC") CLINICAL TRIALS ARE NECESSARY FOR "TRIPLE INHIBITOR THERAPY": INHIBITING PARP, RECEPTORS FOR ANDROGEN, AND RUNX1.
http://scienceblog.cancerresearchuk.org/2014/06/30/its-time-to-be-positive-about-triple-negative-breast-cancer/
TNBC/TRIPLE-NEGATIVE BREAST CANCER PATIENTS AND PROGNOSTIC ROLES (SURVIVAL RATE PREDUCTIONS), AS IT RELATES TO THEIR BRCA1 GENETIC MUTATIONS:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3861604/
Comments
Post a Comment